Clearing Skin Wash

Description

Breakout Clearing Foam is a skin wash formulated by Dermalogica, designed for active clearing of the skin. The product is presented in a volume of 8.4 US fluid ounces (250 mL ℮) and is characterized by its clearing appearance.

Uses and Indications

This drug is indicated for the treatment of acne.

There are no teratogenic effects associated with this medication. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

A pea-sized amount of the product should be worked into a lather using wet hands. The lather is then to be applied to a dampened face and neck, with the product being massaged in circular motions, particularly focusing on areas prone to congestion and oiliness. After application, the product must be rinsed thoroughly with warm water.

For optimal results, it is recommended to follow this cleansing step with the Active Clearing regimen. In cases where bothersome dryness or peeling occurs, the frequency of application should be reduced to once daily or every other day, as needed.

Contraindications

Use of this product is contraindicated in the following situations:

Contact with the eyes should be strictly avoided. In the event of contact, it is imperative to flush the eyes thoroughly with water.

If any irritation develops during use, the product should be discontinued immediately.

Warnings and Precautions

For external use only. It is imperative that this product is not applied in or near the eyes. In the event of contact with the eyes, it is essential to flush thoroughly with water to mitigate any potential irritation.

Healthcare professionals should advise patients to discontinue use if any irritation develops. The likelihood of skin irritation and dryness may increase if this product is used concurrently with other topical acne medications. Therefore, it is recommended that only one topical acne medication be utilized at a time to minimize the risk of adverse effects.

This product should be stored out of reach of children. In cases of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Side Effects

Patients using this product should be aware that it is for external use only. It is contraindicated for use in or near the eyes; in the event of contact, the affected area should be flushed thoroughly with water.

Skin irritation and dryness are common adverse reactions associated with this product, particularly when used concurrently with other topical acne medications. If irritation develops, it is advised to discontinue use and limit the application to one topical acne medication at a time to minimize the risk of adverse effects.

Additionally, this product should be kept out of reach of children. In the case of accidental ingestion, it is crucial to seek medical assistance or contact a Poison Control Center immediately.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate these effects, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the medications is recommended to allow the skin to recover. Monitoring for signs of irritation is essential when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Clearing Skin Wash (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

Elderly patients may not have specific dosage adjustments, safety concerns, or special precautions outlined in the drug insert for Clearing Skin Wash (salicylic acid liquid). As there is no available information regarding the use of this product in geriatric populations, healthcare providers should exercise caution when prescribing it to elderly patients.

It is advisable to monitor these patients closely for any adverse effects or unusual responses to treatment, given the lack of targeted data. Individual patient factors, including comorbidities and concurrent medications, should be considered when determining the appropriateness of this product for geriatric patients.

Pregnancy

The safety of this medication during pregnancy has not been specifically established. There are no available data regarding the potential risks or fetal impacts associated with its use in pregnant patients. Healthcare professionals should exercise caution when prescribing this medication to women of childbearing potential and consider the lack of information regarding its effects on pregnancy outcomes. It is advisable to weigh the potential benefits against any unknown risks when making treatment decisions for pregnant patients.

Lactation

There are no specific statements regarding the use of this medication in lactating mothers or its effects on breastfed infants. Healthcare professionals should consider the absence of data when advising lactating mothers about the use of this medication.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms of overdosage may vary depending on the specific substance involved; therefore, a thorough assessment and monitoring of the patient are essential.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous evaluation and appropriate interventions should be implemented based on the clinical presentation and severity of symptoms.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event of swallowing the medication, patients should seek medical assistance or contact a Poison Control Center immediately.

Patients should be informed about the importance of avoiding contact with the eyes. If contact occurs, they should flush the eyes thoroughly with water to minimize irritation. Should any irritation develop during use, patients are advised to discontinue the medication.

Additionally, healthcare providers should caution patients that skin irritation and dryness may be more pronounced if they are using another topical acne medication concurrently. It is recommended that patients use only one topical acne medication at a time to reduce the risk of irritation.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from direct light exposure to protect its quality. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

The route of administration for the product is topical. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Clearing Skin Wash, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)